Asked by: Baroness Merron (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they are considering using the new screening technology, developed by OsteoSight, for estimating bone mineral density from routine X-rays that has been approved by the Food and Drug Administration in the United States to give earlier diagnosis of osteoporosis.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
OsteoSight is not a registered product with the Medicines and Healthcare Products Regulatory Agency, therefore the Government is not currently considering the use of this technology. However, we will continue to explore areas where artificial intelligence can be deployed in health and care to support clinicians, transform patient experience and improve outcomes.
Asked by: Baroness Altmann (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to ask the Royal Osteoporosis Society to establish ‘lived experience’ focus groups for people with Osteoporosis to inform their Major Conditions Strategy; and what plans they have to include the issue of bone fractures in the Strategy.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Major Conditions Strategy will look to tackle the six major condition groups including musculoskeletal (MSK) conditions. In August 2023, we set out our initial plans in the online-only Major Conditions Strategy:Case for change and our strategic framework including that we will look to, together with NHS England, explore supporting the provision of fracture liaison services.
There are no current plans to ask the Royal Osteoporosis Society to establish ‘lived experience’ focus groups for people with Osteoporosis. However, the Department has worked closely with stakeholders to develop the Major Conditions Strategy including people with lived experience and organisations representing patients, carers, and conditions. This includes engagement with the Arthritis and Musculoskeletal Alliance, an umbrella body bringing together patient organisations and professional bodies representing the breadth of MSK health. The development of the strategy has also been informed by the Call for Evidence, which received over 400 responses from both individuals and organisations. Our intention is to publish the Major Conditions Strategy early this year.
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022Found: on bone metabolism (252).
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 17 October 2022Found: recurrence 1 0 Exercise tolerance decreased 7 0 Foaming at mouth 4 0 General physical health
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 29 August 2022Found: However, long -term human data on bone and sexual maturatio n are missing and therefore no solid conclusions
Mentions:
1: Margaret Greenwood (Lab - Wirral West) , which is led by the Royal Osteoporosis Society and the Sunday Express and backed by many organisations - Speech Link
2: Mims Davies (Con - Mid Sussex) have the fair rights and access that we all want for them.My mum lived with osteoporosis and rheumatoid - Speech Link
3: Mims Davies (Con - Mid Sussex) experiences and outcomes in relation to osteoporosis. - Speech Link
Dec. 22 2023
Source Page: Medicines: packaging, labelling and patient information leafletsFound: Medicines: packaging, labelling and patient information leaflets
Asked by: Baroness Altmann (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what estimate they have made of the potential cost savings to (1) the NHS, and (2) employers, in the next 20 years as a result of early detection and treatment of osteoporosis.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
We have made no estimate of the potential cost savings to the National Health Service, and to employers, in the next 20 years as a result of early detection and treatment of osteoporosis.
Information on the number of working days lost each year that result from bone fractures is not available. The Office for National Statistics (ONS) Sickness absence in the United Kingdom labour market publication is produced from data collected from the Labour Force Survey; however, this survey does not specifically ask the question of sick days taken due to fractures.
A document is attached with tables showing, firstly, the number of deaths where bone fractures were the secondary cause of death, by broad age group and sex, registered between 2014 and 2023 in England and Wales; and secondly, the number of deaths involving bone fractures, by broad age group and sex, registered between 2014 and 2023 in England and Wales.
Government will continue to consider options for further work to support those with osteoporosis and at risk of fractures, including working together with NHS England to explore supporting the provision of fracture liaison service.
Asked by: Baroness Altmann (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what estimates they have made of the number of (1) deaths and (2) working days lost, each year that result from bone fractures among (a) women, and (b) men.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
We have made no estimate of the potential cost savings to the National Health Service, and to employers, in the next 20 years as a result of early detection and treatment of osteoporosis.
Information on the number of working days lost each year that result from bone fractures is not available. The Office for National Statistics (ONS) Sickness absence in the United Kingdom labour market publication is produced from data collected from the Labour Force Survey; however, this survey does not specifically ask the question of sick days taken due to fractures.
A document is attached with tables showing, firstly, the number of deaths where bone fractures were the secondary cause of death, by broad age group and sex, registered between 2014 and 2023 in England and Wales; and secondly, the number of deaths involving bone fractures, by broad age group and sex, registered between 2014 and 2023 in England and Wales.
Government will continue to consider options for further work to support those with osteoporosis and at risk of fractures, including working together with NHS England to explore supporting the provision of fracture liaison service.
Dec. 11 2023
Source Page: SACN vitamin D and health reportFound: SACN vitamin D and health report